Expression Analysis agrees to purchase PacBio RS DNA sequencing system from Pacific Biosciences

Expression Analysis agrees to purchase PacBio RS DNA sequencing system from Pacific Biosciences
Expression Analysis, a leading provider of genomic services for clinical trials and research, announced today that it has agreed to purchase a PacBio RS DNA sequencing system from northern-California based Pacific Biosciences, whose third-generation DNA sequencing technology is expected to revolutionize the field of genetic analysis through the use of single molecule real time detection of …

Read more on News-Medical-Net

Thrive: Building successful companies in the Madison Wisconsin USA region

Three Madison Wisconsin biotech/biomedical businesses discuss what makes their business successful in the Madison Region–from a startup (FluGen), a business just about to enter clinical trials (Quintessence) and a global headquarters with an IPO (TomoTherapy).

Data from three Phase II clinical trials of PS-targeting antibody to be presented at 2010 ASCO Annual Meeting

Data from three Phase II clinical trials of PS-targeting antibody to be presented at 2010 ASCO Annual Meeting
Peregrine Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing innovative monoclonal antibodies for the treatment of cancer and viral infections, will present data from three Phase II clinical trials highlighting the clinical potential of its unique phosphatidylserine -targeting antibody bavituximab for the treatment of solid tumors.

Read more on News-Medical-Net

Whistleblower Exposes The HPV Vaccine Industry

This research scientist talks about the dangers of vaccines and takes you behind the scenes of The Bill and Melinda Gates Foundation, Merck & Co., Inc. and other biotech/pharmaceutical industries. 00:00 “Cynthia” provides background on herself 00:44 moving away from drugs towards vaccines 01:07 genetic modifications 02:23 3rd world testing for easy approval 03:10 HPV vaccine bad side effects 04:00 experimental vaccines 06:08 side effects swept under carpet 08:00 53% of all drugs in clinical trials toxic 08:27 HPV vaccinations harming people in 3rd world countries Link it, rip it, download it, record it, spread it before it gets censored or taken down.

Lytix Biopharma As Update On Phase I Progress With OncoporeTM For Solid Tumours

Lytix Biopharma As Update On Phase I Progress With OncoporeTM For Solid Tumours
The Norwegian pharmaceutical company Lytix Biopharma AS provided an update at the recent BIO conference in Chicago on Phase I clinical trials of OncoporeTM (LTX-315) for the treatment of cancer. During a session hosted by the European Cancer Cluster (Norwegian Oslo Cancer Cluster and French Cancer-Bio-Santé Cluster) at the recent BIO conference in Chicago, Head of Lytix Biopharma Business …

Read more on Medical News Today

Next Page »